DanCann Pharma A/S publishes Q1-2023 report
COPENHAGEN, Denmark, May 31, 2023 /PRNewswire/ -- DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann...
Stay updated with breaking news from Danish Pilot Programme. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
COPENHAGEN, Denmark, May 31, 2023 /PRNewswire/ -- DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann...
/PRNewswire/ -- DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby announce...
/PRNewswire/ -- DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby announce...
STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO Reference is made to today’s formal announcement, that STENOCARE has been approved by the Danish Medicines Agency to once again sell medical cannabis oil under the Danish Pilot Programme. This press release serves as an elaboration on the perspectives.
STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO STENOCARE A/S (“STENOCARE”) hereby announces that it has received approval from The Danish Medicines Agency to sell a new medical cannabis oil product to Danish patients. With this, STENOCARE once again becomes the only supplier of medical cannabis oil products under the Danish Pilot Programme.